I do appreciate the study link... Kudos for that...
"Thirty-nine young male patients with CHH and 40 age-matched healthy males were enrolled in the present study."
Que? 79 people are a large sample? No, no it isn't.
And even in this very small study (show me some cohort metas if you want to talk about sufficient sample sizes) as it relates to the OP's topic "anxiety":
"improvement in the BAI (Beck Anxiety Inventory) score was not statistically significant (p=0.135)" Though I don't think it matters because of what I note below.
I did find this very encouraging though:
"Patients previously diagnosed with such conditions or those on any related medications were not enrolled in the present study"
Hallelujah! So many studies seems to find the presence of Xanax being randomly consumed like Pez throughout each group to be of no concern.
This was also not a blind study at all. The test subject knew they were being administered Test and the controls knew that they weren't.
Why is that important?
Because of these evaluation methods:
"SF-36 is a self-evaluation scale designed to assess the quality of life."
"BDI is a self-report scale with 21 items"
"BAI is a self-report scale with 21 items"
Studies that do this without being blind WASTE their fucking time with all the other control protocols because this simple fact of allowing your subjects to not only know they they are being treated, what they are treated with, and WHY you are treating them throws everything into the Land of Nod.
Making this a double-blind would have saved it (partially), but they didn't even single blind it.
Even in a double blind, having 3rd party evaluations etc would have been far more compelling than the fucking self reports.
Honestly, why go to all that effort an not blind the fucking thing?
Still... Thanks for the link
@FNP_Doc
Good business...
https://www.jstage.jst.go.jp/article/endocrj/59/12/59_EJ12-0134/_pdf